Fusobacterium nucleatum Blocks Colorectal Cancer Ferroptosis to Drive Oxaliplatin Chemoresistance
Researchers have identified that the gut bacterium Fusobacterium nucleatum triggers oxaliplatin resistance in colorectal cancer cells by activating the TLR4/AP-1 ...
















